CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 153 filers reported holding CONMED CORP in Q4 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,808,245 | -25.9% | 2,467,112 | -0.2% | 0.07% | -23.3% |
| Q2 2023 | $335,926,467 | +34.7% | 2,472,047 | +2.9% | 0.09% | +26.8% |
| Q1 2023 | $249,445,755 | +28.4% | 2,401,750 | +9.5% | 0.07% | +20.3% |
| Q4 2022 | $194,333,804 | +39.4% | 2,192,394 | +26.0% | 0.06% | +28.3% |
| Q3 2022 | $139,449,000 | -4.9% | 1,739,412 | +13.6% | 0.05% | 0.0% |
| Q2 2022 | $146,569,000 | -13.4% | 1,530,589 | +34.3% | 0.05% | +9.5% |
| Q1 2022 | $169,251,000 | +5.9% | 1,139,356 | +1.1% | 0.04% | +20.0% |
| Q4 2021 | $159,771,000 | +19.3% | 1,127,056 | +10.1% | 0.04% | +12.9% |
| Q3 2021 | $133,969,000 | +3.0% | 1,023,995 | +8.2% | 0.03% | +3.3% |
| Q2 2021 | $130,008,000 | +19.6% | 945,995 | +13.7% | 0.03% | +11.1% |
| Q1 2021 | $108,663,000 | +35.1% | 832,095 | +15.8% | 0.03% | +28.6% |
| Q4 2020 | $80,450,000 | +47.2% | 718,300 | +3.4% | 0.02% | +31.2% |
| Q3 2020 | $54,636,000 | +29.8% | 694,500 | +18.8% | 0.02% | +23.1% |
| Q2 2020 | $42,078,000 | -49.3% | 584,500 | -59.7% | 0.01% | -60.6% |
| Q1 2020 | $83,070,000 | -65.6% | 1,450,500 | -32.7% | 0.03% | -54.2% |
| Q4 2019 | $241,178,000 | +10.5% | 2,156,651 | -5.0% | 0.07% | 0.0% |
| Q3 2019 | $218,276,000 | +12.4% | 2,270,162 | 0.0% | 0.07% | +16.1% |
| Q2 2019 | $194,258,000 | +22.8% | 2,270,162 | +19.4% | 0.06% | +24.0% |
| Q1 2019 | $158,139,000 | +61.9% | 1,901,162 | +24.9% | 0.05% | +47.1% |
| Q4 2018 | $97,691,000 | -28.3% | 1,521,662 | -11.5% | 0.03% | -15.0% |
| Q3 2018 | $136,179,000 | +16.0% | 1,719,000 | +7.2% | 0.04% | +25.0% |
| Q2 2018 | $117,384,000 | +39.6% | 1,603,606 | +20.8% | 0.03% | +33.3% |
| Q1 2018 | $84,077,000 | +65.8% | 1,327,600 | +33.4% | 0.02% | +60.0% |
| Q4 2017 | $50,716,000 | +9.7% | 995,014 | +12.9% | 0.02% | +7.1% |
| Q3 2017 | $46,226,000 | +3.0% | 881,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $44,878,000 | -6.7% | 881,000 | -18.7% | 0.01% | -6.7% |
| Q1 2017 | $48,096,000 | -12.9% | 1,083,000 | -13.4% | 0.02% | -16.7% |
| Q4 2016 | $55,244,000 | +10.3% | 1,250,719 | 0.0% | 0.02% | +5.9% |
| Q3 2016 | $50,104,000 | -16.1% | 1,250,719 | 0.0% | 0.02% | -15.0% |
| Q2 2016 | $59,697,000 | +13.8% | 1,250,719 | 0.0% | 0.02% | +11.1% |
| Q1 2016 | $52,455,000 | -11.3% | 1,250,719 | -6.8% | 0.02% | -10.0% |
| Q4 2015 | $59,145,000 | -7.7% | 1,342,689 | 0.0% | 0.02% | -13.0% |
| Q3 2015 | $64,100,000 | -7.8% | 1,342,689 | +12.6% | 0.02% | 0.0% |
| Q2 2015 | $69,496,000 | +71.4% | 1,192,648 | +48.5% | 0.02% | +64.3% |
| Q1 2015 | $40,543,000 | +12.3% | 803,000 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $36,103,000 | +22.0% | 803,000 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $29,583,000 | +66.3% | 803,000 | +99.3% | 0.01% | +66.7% |
| Q2 2014 | $17,792,000 | -13.8% | 403,000 | -15.2% | 0.01% | -14.3% |
| Q1 2014 | $20,639,000 | +2.2% | 475,000 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $20,188,000 | +25.0% | 475,000 | 0.0% | 0.01% | +16.7% |
| Q3 2013 | $16,145,000 | +8.8% | 475,000 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $14,839,000 | – | 475,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |